ebomi
Colour theme
Sign in
Insider · CIK 0001252525

Wheeler Kurt

CIK 0001252525 Name as filed on the most recent filing

Filed as Wheeler Kurt (115)

191 transaction lines · from 115 filings · filed 2004-02-23 to 2018-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

24 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2012-07-06 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 195,324, disposed Open Form 4 filing 0001209191-12-037738
2012-07-03 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 28,481, disposed Open Form 4 filing 0001209191-12-037223
2012-07-02 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 23,301, disposed Open Form 4 filing 0001209191-12-037223
2012-06-28 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 5,655, disposed Open Form 4 filing 0001209191-12-036059
2012-06-19 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 3,480, disposed Open Form 4 filing 0001209191-12-034920
2012-06-15 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 421, disposed Open Form 4 filing 0001209191-12-034491
2012-06-06 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 2,436, disposed Open Form 4 filing 0001209191-12-032788
2012-06-05 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 8,571, disposed Open Form 4 filing 0001209191-12-032788
2012-05-31 S, Open-market sale Achillion Pharmaceuticals IncACHN 2 lines 9,868,215, disposed Open Form 4 filing 0001012975-12-000163
2012-05-31 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 8,955, disposed Open Form 4 filing 0001209191-12-031979
2012-05-30 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 15,302, disposed Open Form 4 filing 0001209191-12-031979
2012-05-29 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 4,622, disposed Open Form 4 filing 0001209191-12-031979
2012-05-25 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 87,905, disposed Open Form 4 filing 0001209191-12-031979
2012-05-23 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 40,629, disposed Open Form 4 filing 0001209191-12-031979
2012-05-22 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 86,990, disposed Open Form 4 filing 0001209191-12-031979
2011-10-27 S, Open-market sale Zalicus Inc.ZLCS 760,971, disposed Open Form 4 filing 0001209191-11-053081
2011-10-26 S, Open-market sale Zalicus Inc.ZLCS 79,560, disposed Open Form 4 filing 0001209191-11-052898
2011-10-25 S, Open-market sale Zalicus Inc.ZLCS 207,264, disposed Open Form 4 filing 0001209191-11-052898
2011-10-24 S, Open-market sale Zalicus Inc.ZLCS 259,560, disposed Open Form 4 filing 0001209191-11-052585
2011-10-21 S, Open-market sale Zalicus Inc.ZLCS 71,502, disposed Open Form 4 filing 0001209191-11-052585
2011-10-20 S, Open-market sale Zalicus Inc.ZLCS 437,750, disposed Open Form 4 filing 0001209191-11-052368
2011-10-19 S, Open-market sale Zalicus Inc.ZLCS 35,513, disposed Open Form 4 filing 0001209191-11-052368
2011-10-17 S, Open-market sale Zalicus Inc.ZLCS 20,037, disposed Open Form 4 filing 0001209191-11-052139
2011-10-14 S, Open-market sale Zalicus Inc.ZLCS 40,494, disposed Open Form 4 filing 0001209191-11-051841
2011-10-13 S, Open-market sale Zalicus Inc.ZLCS 5,100, disposed Open Form 4 filing 0001209191-11-051841
2011-10-12 S, Open-market sale Zalicus Inc.ZLCS 13,443,600, disposed Open Form 4 filing 0001209191-11-051707
2011-10-11 S, Open-market sale Zalicus Inc.ZLCS 210,630, disposed Open Form 4 filing 0001209191-11-051707
2011-10-10 S, Open-market sale Zalicus Inc.ZLCS 239,200, disposed Open Form 4 filing 0001209191-11-051379
2011-10-07 S, Open-market sale Zalicus Inc.ZLCS 283,456, disposed Open Form 4 filing 0001209191-11-051379
2011-10-06 S, Open-market sale Zalicus Inc.ZLCS 173,400, disposed Open Form 4 filing 0001209191-11-051055
2011-10-05 S, Open-market sale Zalicus Inc.ZLCS 33,786, disposed Open Form 4 filing 0001209191-11-051055
2011-09-30 S, Open-market sale Zalicus Inc.ZLCS 23,774, disposed Open Form 4 filing 0001209191-11-051055
2011-09-29 S, Open-market sale Zalicus Inc.ZLCS 54,876, disposed Open Form 4 filing 0001209191-11-051055
2011-09-28 S, Open-market sale Zalicus Inc.ZLCS 102,000, disposed Open Form 4 filing 0001209191-11-051055
2011-09-27 S, Open-market sale Zalicus Inc.ZLCS 218,000, disposed Open Form 4 filing 0001209191-11-049252
2011-09-26 S, Open-market sale Zalicus Inc.ZLCS 233,100, disposed Open Form 4 filing 0001209191-11-049252
2011-09-16 P, Open-market purchase Zogenix, Inc.ZGNX 7,000,000, acquired Open Form 4 filing 0001012975-11-000265
2010-11-29 P, Open-market purchase Zogenix, Inc.ZGNX 7,000,000, acquired Open Form 4 filing 0001181431-10-058221
2010-11-09 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 5,773,920, disposed Open Form 4 filing 0001012975-10-000397
2010-11-08 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 227,593, disposed Open Form 4 filing 0001012975-10-000397
2010-11-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 1,597,377, disposed Open Form 4 filing 0001012975-10-000385
2010-11-03 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 6,332,539, disposed Open Form 4 filing 0001012975-10-000385
2010-11-03 P, Open-market purchase Pharmathene, IncPIP 1,505,000, acquired Open Form 4 filing 0001209191-10-053398
2010-11-02 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 5,800,400, disposed Open Form 4 filing 0001012975-10-000382
2010-11-01 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 13,273,424, disposed Open Form 4 filing 0001012975-10-000382
2010-10-29 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 7,215,647, disposed Open Form 4 filing 0001012975-10-000382
2010-10-11 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 1,093,445, disposed Open Form 4 filing 0001012975-10-000362
2010-10-08 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 836,792, disposed Open Form 4 filing 0001012975-10-000362
2010-08-20 P, Open-market purchase Achillion Pharmaceuticals IncACHN 12,140,000, acquired Open Form 4 filing 0001012975-10-000292

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 7
  • Open-market sale 17
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. WHEELER KURT, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001252525

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.